[Rare cervical soft tissue tumor].

@article{Send2017RareCS,
  title={[Rare cervical soft tissue tumor].},
  author={T Send and Lj Isselstein and K W G Eichhorn and Susanne Greschus and Friedrich Bootz and Tobias van Bremen},
  journal={HNO},
  year={2017},
  volume={65 12},
  pages={
          1018-1022
        }
}
View on PubMed
doi.org

References

SHOWING 1-5 OF 5 REFERENCES
Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.
TLDR
A treatment algorithm approved by the French and the Italian Sarcoma Group is proposed, based on a front-line wait and see approach and subsequent therapy in the case of progression, which should be offered to all patients affected by sporadic DF.
Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution.
  • Xiaodong He, Y. Zhang, Y. Na
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2015
Management and Recurrence Patterns of Desmoids Tumors: A Multi-institutional Analysis of 211 Patients
TLDR
Recurrence remains a problem following resection of desmoid tumors with as many as 50 % of patients experiencing a recurrence within 5 years with the need for more effective adjuvant therapies.
Desmoid tumors: clinical features and treatment options for advanced disease.
TLDR
Treatment options and management strategies for patients with desmoid tumors with a focus on advanced disease are described and watchful waiting may be the most appropriate management in selected asymptomatic patients.